TARS (Tarsus Corp) Kacepetan wutah bathi saben saham ing taun lumaku

Simbol resmi perusahaan Tarsus Pharmaceuticals (TARS)

The non-cyclical demand for ophthalmological drugs ensures the resilience of Tarsus Pharmaceuticals (TARS), which is why data is sourced from GURU.Markets, where the chart level for annual EPS growth is fixed at -878.20. Monopoly ownership of an FDA-approved drug provides access to a massive patient market. The absence of sanction risks and the humanitarian status of its developments guarantee stable business growth within the US.

tarsusrx.com (TARS): Wutah bathi resik saben saham ing taun iki saka 04.07.2022 nganti 15.11.2026

Rincian analitis lan laporan data perusahaan Tarsus Corp (TARS)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan Tarsus Pharma|TARS - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Tarsus Pharmaceuticals|TARS - Nilai Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi saben Saham Tarsus Pharmaceuticals|TARS - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku tarsusrx.com|TARS - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Koefisien Total Utang marang Modal Tarsus Pharmaceuticals|TARS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Tarsus Pharmaceuticals Inc|TARS - Utang perusahaan|Rasio utang marang nilai buku Tarsus Pharmaceuticals, Inc.|TARS - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Tarsus Pharmaceuticals|Rasio likuiditas perantara tarsusrx.com
- data bathi resik lan rasio valuasi:
TARS - Bathi resik|Proyeksi bathi mangsa ngarep Tarsus Pharmaceuticals|TARS - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi tarsusrx.com|TARS - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Tarsus Pharmaceuticals Inc|TARS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Tarsus Pharmaceuticals|TARS - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan tarsusrx.com|TARS - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Tarsus Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
TARS - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan Tarsus Pharma|TARS - Multiplikator P/S|Rega forward marang dodolan Tarsus Pharmaceuticals
Analisis dhasar perusahaan:Tarsus Corp
Produk seri Tarsus Pharma

This indicator reflects the growth rate of net earnings per share, allowing for an assessment of capital generation efficiency relative to the previous year. By analyzing the annual EPS change ratio, an investor can see the impact of the pricing power of Tarsus Pharmaceuticals (TARS), whose monopoly in the blepharitis treatment market and patent protection translate directly into the accelerated growth of this metric.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku SMMT (Summit Therapeutics Inc)|MRNA (Moderna Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Vaxcyte, Inc. PCVX|Wutah bathi ing taun lumaku CRMD|Wutah bathi resik saben saham ing taun iki Seres MCRB|Spero Therapeutics, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku SCYX (Scynexis)|AN2 Therapeutics Inc - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki PolyPid PYPD|YS Biopharma (LSB) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Iterum Therapeutics, plc (ITRM)|Wutah bathi saben saham ing taun lumaku BiomX|Wutah bathi saben saham ing taun iki SNGX (soligenix.com)|Wutah bathi saben saham ing taun lumaku 60 Degrees Pharma (SXTP)|Prakiraan wutah bathi resik saben saham ing taun iki Oragenics Inc.|Wutah bathi saben saham ing taun lumaku OpGen Corporation OPGN